These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1830252)

  • 1. Exploratory analysis of population pharmacokinetic data from clinical trials with application to isradipine.
    Laplanche R; Fertil B; Nüesch E; Jais JP; Niederberger W; Steimer JL
    Clin Pharmacol Ther; 1991 Jul; 50(1):39-54. PubMed ID: 1830252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of renal function on the disposition of isradipine.
    Chandler MH; Schran HF; Cutler RE; Smith AJ; Gonasun LM; Blouin RA
    J Clin Pharmacol; 1988 Dec; 28(12):1076-80. PubMed ID: 2977394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of isradipine and of its major metabolites in biological fluids by capillary gas chromatography and chemical ionization mass spectrometry.
    Jean C; Laplanche R
    J Chromatogr; 1988 Jun; 428(1):61-9. PubMed ID: 2971669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of oral isradipine in normal volunteers.
    Clifton GD; Blouin RA; Dilea C; Schran HF; Hassell AE; Gonasun LM; Foster TS
    J Clin Pharmacol; 1988 Jan; 28(1):36-42. PubMed ID: 2965165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of isradipine in young and old rats: effect of mode of administration.
    Tse FL; Jaffe JM; Hassell AE; Schran HF
    J Pharm Pharmacol; 1989 Sep; 41(9):657-60. PubMed ID: 2573717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of isradipine in human plasma using LC-MS/MS for pharmacokinetic and bioequivalence study.
    Park JH; Park YS; Rhim SY; Jhee OH; Kim SH; Yang SC; Lee MH; Shaw LM; Kang JS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(1-2):59-64. PubMed ID: 19041284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of isradipine and its pyridine metabolite in serum by capillary column gas chromatography with nitrogen-selective detection.
    Christensen HR; Angelo HR; Skajaa K
    J Chromatogr; 1992 Feb; 574(1):161-5. PubMed ID: 1385820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of isradipine and the oxidative pyridine metabolite in human plasma by high-performance liquid chromatography.
    Boutagy J; Rumble F; Dunagan F
    J Chromatogr; 1989 Feb; 487(2):483-8. PubMed ID: 2524499
    [No Abstract]   [Full Text] [Related]  

  • 9. Enantioselective determination of isradipine in human serum using chiral stationary phase liquid chromatography and gas chromatography with nitrogen selective detection.
    Rask HS; Angelo HR; Christensen HR
    Chirality; 1998; 10(9):808-12. PubMed ID: 9839430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals.
    Johnson BA; Javors MA; Lam YW; Wells LT; Tiouririne M; Roache JD; Ait-Daoud N; Lawson K
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):15-20. PubMed ID: 15610940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist.
    Burger W; Neidel S; Kober G
    Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isradipine, a calcium antagonist in hypertension].
    Christensen HR; Graudal N
    Ugeskr Laeger; 1990 Aug; 152(34):2448-50. PubMed ID: 2144928
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
    Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP
    Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isradipine for hypertension.
    Med Lett Drugs Ther; 1991 May; 33(845):51-2. PubMed ID: 1827655
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic and pharmacodynamic effects of isradipine in patients with arterial hypertension].
    Svetyĭ LI; Alekhin SN
    Eksp Klin Farmakol; 2002; 65(5):35-8. PubMed ID: 12596512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
    Nelson EB; Pool JL; Taylor AA
    Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of blood pressure measurements in determining anomalies in duration of effect of an antihypertensive drug: assessment of isradipine.
    Stokes GS; Shenfield GM; Johnston HJ; Marwood JF; Dunagan F; Boutagy J
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S65-9. PubMed ID: 1695306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isradipine--another calcium-channel blocker for the treatment of hypertension and angina.
    Lopez LM; Santiago TM
    Ann Pharmacother; 1992 Jun; 26(6):789-99. PubMed ID: 1535246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
    Pinquier JL; Urien S; Chaumet-Riffaud P; Tillement JP
    Br J Clin Pharmacol; 1989 Nov; 28(5):587-92. PubMed ID: 2531607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
    Fitton A; Benfield P
    Drugs; 1990 Jul; 40(1):31-74. PubMed ID: 2143980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.